LIFNano Therapeutics Company

LIFNano Therapeutics specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor.
Technology: Apps & Platforms
Industry: Telemedicine
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2015
Employees Number: 1-10
Funding Status: M&A
Investors Number: 2
Total Funding: £1M
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
info@lifnano.com
https://twitter.com/LIFNanoRx
Register and Claim Ownership